Search by Drug Name or NDC
NDC 53002-1401-01 Fluticasone Propionate 220 ug/1 Details
Fluticasone Propionate 220 ug/1
Fluticasone Propionate is a RESPIRATORY (INHALATION) AEROSOL, METERED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by RPK Pharmaceuticals, Inc.. The primary component is FLUTICASONE PROPIONATE.
MedlinePlus Drug Summary
Fluticasone oral inhalation is used to prevent difficulty breathing, chest tightness, wheezing, and coughing caused by asthma in adults and children. It is in a class of medications called corticosteroids. Fluticasone works by decreasing swelling and irritation in the airways to allow for easier breathing.
Related Packages: 53002-1401-01Last Updated: 04/21/2024
MedLinePlus Full Drug Details: Fluticasone Oral Inhalation
Product Information
NDC | 53002-1401 |
---|---|
Product ID | 53002-1401_33ca102e-49cd-42e5-a359-a5e983b09fff |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | Fluticasone Propionate |
Proprietary Name Suffix | HFA |
Non-Proprietary Name | fluticasone propionate |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | AEROSOL, METERED |
Route | RESPIRATORY (INHALATION) |
Active Ingredient Strength | 220 |
Active Ingredient Units | ug/1 |
Substance Name | FLUTICASONE PROPIONATE |
Labeler Name | RPK Pharmaceuticals, Inc. |
Pharmaceutical Class | Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC] |
DEA Schedule | n/a |
Marketing Category | NDA AUTHORIZED GENERIC |
Application Number | NDA021433 |
Listing Certified Through | 2024-12-31 |
Package
NDC 53002-1401-01 (53002140101)
NDC Package Code | 53002-1401-1 |
---|---|
Billing NDC | 53002140101 |
Package | 1 INHALER in 1 CARTON (53002-1401-1) / 120 AEROSOL, METERED in 1 INHALER |
Marketing Start Date | 2022-11-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |